Global TB Diagnostic Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global TB Diagnostic Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Radiographic Method
1.2.3 Diagnostic Laboratory Methods
1.2.4 Nucleic Acid Testing
1.2.5 Phage Assay
1.2.6 Detection of Latent Infection
1.2.7 Cytokine Detection Assay
1.2.8 Detection of Drug Resistance
1.2.9 Others
1.3 Market by Application
1.3.1 Global TB Diagnostic Market Growth Rate by Application: 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global TB Diagnostic Market Size (2017-2028)
2.2 TB Diagnostic Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.3 Global TB Diagnostic Market Size by Region (2017-2022)
2.4 Global TB Diagnostic Market Size Forecast by Region (2023-2028)
2.5 Global Top TB Diagnostic Countries Ranking by Market Size
3 TB Diagnostic Competitive by Company
3.1 Global TB Diagnostic Revenue by Players
3.1.1 Global TB Diagnostic Revenue by Players (2017-2022)
3.1.2 Global TB Diagnostic Market Share by Players (2017-2022)
3.2 Global TB Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by TB Diagnostic Revenue
3.4 Global TB Diagnostic Market Concentration Ratio
3.4.1 Global TB Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by TB Diagnostic Revenue in 2021
3.5 Global TB Diagnostic Key Players Head office and Area Served
3.6 Key Players TB Diagnostic Product Solution and Service
3.7 Date of Enter into TB Diagnostic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Global TB Diagnostic Breakdown Data by Type
4.1 Global TB Diagnostic Historic Revenue by Type (2017-2022)
4.2 Global TB Diagnostic Forecasted Revenue by Type (2023-2028)
5 Global TB Diagnostic Breakdown Data by Application
5.1 Global TB Diagnostic Historic Market Size by Application (2017-2022)
5.2 Global TB Diagnostic Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America TB Diagnostic Revenue by Company (2020-2022)
6.2 North America TB Diagnostic Revenue by Type (2017-2028)
6.3 North America TB Diagnostic Revenue by Application (2017-2028)
6.4 North America TB Diagnostic Revenue by Country (2017-2028)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe TB Diagnostic Revenue by Company (2020-2022)
7.2 Europe TB Diagnostic Revenue by Type (2017-2028)
7.3 Europe TB Diagnostic Revenue by Application (2017-2028)
7.4 Europe TB Diagnostic Revenue by Country (2017-2028)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific TB Diagnostic Revenue by Company (2020-2022)
8.2 Asia Pacific TB Diagnostic Revenue by Type (2017-2028)
8.3 Asia Pacific TB Diagnostic Revenue by Application (2017-2028)
8.4 Asia Pacific TB Diagnostic Revenue by Region (2017-2028)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Vietnam
9 Latin America
9.1 Latin America TB Diagnostic Revenue by Company (2020-2022)
9.2 Latin America TB Diagnostic Revenue by Type (2017-2028)
9.3 Latin America TB Diagnostic Revenue by Application (2017-2028)
9.4 Latin America TB Diagnostic Revenue by Country (2017-2028)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa TB Diagnostic Revenue by Company (2020-2022)
10.2 Middle East and Africa TB Diagnostic Revenue by Type (2017-2028)
10.3 Middle East and Africa TB Diagnostic Revenue by Application (2017-2028)
10.4 Middle East and Africa TB Diagnostic Revenue by Country (2017-2028)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 U.A.E
11 Company Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories TB Diagnostic Products and Services
11.1.4 Abbott Laboratories TB Diagnostic Revenue in TB Diagnostic Business (2017-2022)
11.1.5 Abbott Laboratories TB Diagnostic SWOT Analysis
11.1.6 Abbott Laboratories Recent Developments
11.2 Abbott
11.2.1 Abbott Company Details
11.2.2 Abbott Business Overview
11.2.3 Abbott TB Diagnostic Products and Services
11.2.4 Abbott TB Diagnostic Revenue in TB Diagnostic Business (2017-2022)
11.2.5 Abbott TB Diagnostic SWOT Analysis
11.2.6 Abbott Recent Developments
11.3 Becton Dickinson and Company
11.3.1 Becton Dickinson and Company Company Details
11.3.2 Becton Dickinson and Company Business Overview
11.3.3 Becton Dickinson and Company TB Diagnostic Products and Services
11.3.4 Becton Dickinson and Company TB Diagnostic Revenue in TB Diagnostic Business (2017-2022)
11.3.5 Becton Dickinson and Company TB Diagnostic SWOT Analysis
11.3.6 Becton Dickinson and Company Recent Developments
11.4 bioMrieux
11.4.1 bioMrieux Company Details
11.4.2 bioMrieux Business Overview
11.4.3 bioMrieux TB Diagnostic Products and Services
11.4.4 bioMrieux TB Diagnostic Revenue in TB Diagnostic Business (2017-2022)
11.4.5 bioMrieux TB Diagnostic SWOT Analysis
11.4.6 bioMrieux Recent Developments
11.5 Cepheid
11.5.1 Cepheid Company Details
11.5.2 Cepheid Business Overview
11.5.3 Cepheid TB Diagnostic Products and Services
11.5.4 Cepheid TB Diagnostic Revenue in TB Diagnostic Business (2017-2022)
11.5.5 Cepheid TB Diagnostic SWOT Analysis
11.5.6 Cepheid Recent Developments
11.6 F. Hoffman La Roche
11.6.1 F. Hoffman La Roche Company Details
11.6.2 F. Hoffman La Roche Business Overview
11.6.3 F. Hoffman La Roche TB Diagnostic Products and Services
11.6.4 F. Hoffman La Roche TB Diagnostic Revenue in TB Diagnostic Business (2017-2022)
11.6.5 F. Hoffman La Roche TB Diagnostic SWOT Analysis
11.6.6 F. Hoffman La Roche Recent Developments
11.7 Hain Lifescience
11.7.1 Hain Lifescience Company Details
11.7.2 Hain Lifescience Business Overview
11.7.3 Hain Lifescience TB Diagnostic Products and Services
11.7.4 Hain Lifescience TB Diagnostic Revenue in TB Diagnostic Business (2017-2022)
11.7.5 Hain Lifescience TB Diagnostic SWOT Analysis
11.7.6 Hain Lifescience Recent Developments
11.8 Hologic Corporation
11.8.1 Hologic Corporation Company Details
11.8.2 Hologic Corporation Business Overview
11.8.3 Hologic Corporation TB Diagnostic Products and Services
11.8.4 Hologic Corporation TB Diagnostic Revenue in TB Diagnostic Business (2017-2022)
11.8.5 Hologic Corporation TB Diagnostic SWOT Analysis
11.8.6 Hologic Corporation Recent Developments
11.9 Thermo Fisher Scientific
11.9.1 Thermo Fisher Scientific Company Details
11.9.2 Thermo Fisher Scientific Business Overview
11.9.3 Thermo Fisher Scientific TB Diagnostic Products and Services
11.9.4 Thermo Fisher Scientific TB Diagnostic Revenue in TB Diagnostic Business (2017-2022)
11.9.5 Thermo Fisher Scientific TB Diagnostic SWOT Analysis
11.9.6 Thermo Fisher Scientific Recent Developments
11.10 Qiagen
11.10.1 Qiagen Company Details
11.10.2 Qiagen Business Overview
11.10.3 Qiagen TB Diagnostic Products and Services
11.10.4 Qiagen TB Diagnostic Revenue in TB Diagnostic Business (2017-2022)
11.10.5 Qiagen TB Diagnostic SWOT Analysis
11.10.6 Qiagen Recent Developments
12 TB Diagnostic Market Dynamics
12.1 TB Diagnostic Market Trends
12.2 TB Diagnostic Market Drivers
12.3 TB Diagnostic Market Challenges
12.4 TB Diagnostic Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
List of TablesTable 1. Global TB Diagnostic Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Radiographic Method
Table 3. Key Players of Diagnostic Laboratory Methods
Table 4. Key Players of Nucleic Acid Testing
Table 5. Key Players of Phage Assay
Table 6. Key Players of Detection of Latent Infection
Table 7. Key Players of Cytokine Detection Assay
Table 8. Key Players of Detection of Drug Resistance
Table 9. Key Players of Others
Table 10. Global TB Diagnostic Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 11. Global TB Diagnostic Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 12. Global TB Diagnostic Revenue by Region (2017-2022) & (US$ Million)
Table 13. Global TB Diagnostic Revenue Market Share by Region (2017-2022)
Table 14. Global TB Diagnostic Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global TB Diagnostic Market Share by Players (2017-2022)
Table 16. Global Top TB Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in TB Diagnostic as of 2021)
Table 17. Ranking of Global Top TB Diagnostic Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by TB Diagnostic Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players TB Diagnostic Product Solution and Service
Table 21. Date of Key Manufacturers Enter into TB Diagnostic Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global TB Diagnostic Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global TB Diagnostic Revenue Market Share by Type (2017-2022)
Table 25. Global TB Diagnostic Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global TB Diagnostic Revenue Market Share by Type (2023-2028)
Table 27. Global TB Diagnostic Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global TB Diagnostic Revenue Market Share by Application (2017-2022)
Table 29. Global TB Diagnostic Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global TB Diagnostic Revenue Market Share by Application (2023-2028)
Table 31. North America TB Diagnostic Revenue by Company (2020-2022) & (US$ Million)
Table 32. North America TB Diagnostic Revenue by Type (2017-2022) & (US$ Million)
Table 33. North America TB Diagnostic Revenue by Type (2023-2028) & (US$ Million)
Table 34. North America TB Diagnostic Revenue by Application (2017-2022) & (US$ Million)
Table 35. North America TB Diagnostic Revenue by Application (2023-2028) & (US$ Million)
Table 36. North America TB Diagnostic Revenue by Country (2017-2022) & (US$ Million)
Table 37. North America TB Diagnostic Revenue by Country (2023-2028) & (US$ Million)
Table 38. Europe TB Diagnostic Revenue by Company (2020-2022) & (US$ Million)
Table 39. Europe TB Diagnostic Revenue by Type (2017-2022) & (US$ Million)
Table 40. Europe TB Diagnostic Revenue by Type (2023-2028) & (US$ Million)
Table 41. Europe TB Diagnostic Revenue by Application (2017-2022) & (US$ Million)
Table 42. Europe TB Diagnostic Revenue by Application (2023-2028) & (US$ Million)
Table 43. Europe TB Diagnostic Revenue by Country (2017-2022) & (US$ Million)
Table 44. Europe TB Diagnostic Revenue by Country (2023-2028) & (US$ Million)
Table 45. Asia Pacific TB Diagnostic Revenue by Company (2020-2022) & (US$ Million)
Table 46. Asia Pacific TB Diagnostic Revenue by Type (2017-2022) & (US$ Million)
Table 47. Asia Pacific TB Diagnostic Revenue by Type (2023-2028) & (US$ Million)
Table 48. Asia Pacific TB Diagnostic Revenue by Application (2017-2022) & (US$ Million)
Table 49. Asia Pacific TB Diagnostic Revenue by Application (2023-2028) & (US$ Million)
Table 50. Asia Pacific TB Diagnostic Revenue by Region (2017-2022) & (US$ Million)
Table 51. Asia Pacific TB Diagnostic Revenue by Region (2023-2028) & (US$ Million)
Table 52. Latin America TB Diagnostic Revenue by Company (2020-2022) & (US$ Million)
Table 53. Latin America TB Diagnostic Revenue by Type (2017-2022) & (US$ Million)
Table 54. Latin America TB Diagnostic Revenue by Type (2023-2028) & (US$ Million)
Table 55. Latin America TB Diagnostic Revenue by Application (2017-2022) & (US$ Million)
Table 56. Latin America TB Diagnostic Revenue by Application (2023-2028) & (US$ Million)
Table 57. Latin America TB Diagnostic Revenue by Country (2017-2022) & (US$ Million)
Table 58. Latin America TB Diagnostic Revenue by Country (2023-2028) & (US$ Million)
Table 59. Middle East and Africa TB Diagnostic Revenue by Company (2020-2022) & (US$ Million)
Table 60. Middle East and Africa TB Diagnostic Revenue by Type (2017-2022) & (US$ Million)
Table 61. Middle East and Africa TB Diagnostic Revenue by Type (2023-2028) & (US$ Million)
Table 62. Middle East and Africa TB Diagnostic Revenue by Application (2017-2022) & (US$ Million)
Table 63. Middle East and Africa TB Diagnostic Revenue by Application (2023-2028) & (US$ Million)
Table 64. Middle East and Africa TB Diagnostic Revenue by Country (2017-2022) & (US$ Million)
Table 65. Middle East and Africa TB Diagnostic Revenue by Country (2023-2028) & (US$ Million)
Table 66. Abbott Laboratories Company Details
Table 67. Abbott Laboratories Business Overview
Table 68. Abbott Laboratories TB Diagnostic Product and Services
Table 69. Abbott Laboratories TB Diagnostic Revenue in TB Diagnostic Business (2017-2022) & (US$ Million)
Table 70. Abbott Laboratories TB Diagnostic SWOT Analysis
Table 71. Abbott Laboratories Recent Developments
Table 72. Abbott Company Details
Table 73. Abbott Business Overview
Table 74. Abbott TB Diagnostic Product and Services
Table 75. Abbott TB Diagnostic Revenue in TB Diagnostic Business (2017-2022) & (US$ Million)
Table 76. Abbott TB Diagnostic SWOT Analysis
Table 77. Abbott Recent Developments
Table 78. Becton Dickinson and Company Company Details
Table 79. Becton Dickinson and Company Business Overview
Table 80. Becton Dickinson and Company TB Diagnostic Product and Services
Table 81. Becton Dickinson and Company TB Diagnostic Revenue in TB Diagnostic Business (2017-2022) & (US$ Million)
Table 82. Becton Dickinson and Company TB Diagnostic SWOT Analysis
Table 83. Becton Dickinson and Company Recent Developments
Table 84. bioMrieux Company Details
Table 85. bioMrieux Business Overview
Table 86. bioMrieux TB Diagnostic Product and Services
Table 87. bioMrieux TB Diagnostic Revenue in TB Diagnostic Business (2017-2022) & (US$ Million)
Table 88. bioMrieux TB Diagnostic SWOT Analysis
Table 89. bioMrieux Recent Developments
Table 90. Cepheid Company Details
Table 91. Cepheid Business Overview
Table 92. Cepheid TB Diagnostic Product and Services
Table 93. Cepheid TB Diagnostic Revenue in TB Diagnostic Business (2017-2022) & (US$ Million)
Table 94. Cepheid TB Diagnostic SWOT Analysis
Table 95. Cepheid Recent Developments
Table 96. F. Hoffman La Roche Company Details
Table 97. F. Hoffman La Roche Business Overview
Table 98. F. Hoffman La Roche TB Diagnostic Product and Services
Table 99. F. Hoffman La Roche TB Diagnostic Revenue in TB Diagnostic Business (2017-2022) & (US$ Million)
Table 100. F. Hoffman La Roche TB Diagnostic SWOT Analysis
Table 101. F. Hoffman La Roche Recent Developments
Table 102. Hain Lifescience Company Details
Table 103. Hain Lifescience Business Overview
Table 104. Hain Lifescience TB Diagnostic Product and Services
Table 105. Hain Lifescience TB Diagnostic Revenue in TB Diagnostic Business (2017-2022) & (US$ Million)
Table 106. Hain Lifescience TB Diagnostic SWOT Analysis
Table 107. Hain Lifescience Recent Developments
Table 108. Hologic Corporation Company Details
Table 109. Hologic Corporation Business Overview
Table 110. Hologic Corporation TB Diagnostic Product and Services
Table 111. Hologic Corporation TB Diagnostic Revenue in TB Diagnostic Business (2017-2022) & (US$ Million)
Table 112. Hologic Corporation TB Diagnostic SWOT Analysis
Table 113. Hologic Corporation Recent Developments
Table 114. Thermo Fisher Scientific Company Details
Table 115. Thermo Fisher Scientific Business Overview
Table 116. Thermo Fisher Scientific TB Diagnostic Product and Services
Table 117. Thermo Fisher Scientific TB Diagnostic Revenue in TB Diagnostic Business (2017-2022) & (US$ Million)
Table 118. Thermo Fisher Scientific TB Diagnostic SWOT Analysis
Table 119. Thermo Fisher Scientific Recent Developments
Table 120. Qiagen Company Details
Table 121. Qiagen Business Overview
Table 122. Qiagen TB Diagnostic Product and Services
Table 123. Qiagen TB Diagnostic Revenue in TB Diagnostic Business (2017-2022) & (US$ Million)
Table 124. Qiagen TB Diagnostic SWOT Analysis
Table 125. Qiagen Recent Developments
Table 126. TB Diagnostic Market Trends
Table 127. TB Diagnostic Market Drivers
Table 128. TB Diagnostic Market Challenges
Table 129. TB Diagnostic Market Restraints
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of FiguresFigure 1. Global TB Diagnostic Sales Market Share by Type: 2021 VS 2028
Figure 2. Radiographic Method Features
Figure 3. Diagnostic Laboratory Methods Features
Figure 4. Nucleic Acid Testing Features
Figure 5. Phage Assay Features
Figure 6. Detection of Latent Infection Features
Figure 7. Cytokine Detection Assay Features
Figure 8. Detection of Drug Resistance Features
Figure 9. Others Features
Figure 10. Global TB Diagnostic Sales Market Share by Application: 2021 VS 2028
Figure 11. Hospitals Case Studies
Figure 12. Clinics Case Studies
Figure 13. Others Case Studies
Figure 14. TB Diagnostic Report Years Considered
Figure 15. Global TB Diagnostic Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 16. Global TB Diagnostic Market Size 2017-2028 (US$ Million)
Figure 17. Global TB Diagnostic Market Size Market Share by Region: 2021 VS 2028
Figure 18. Global TB Diagnostic Revenue Market Share by Region in 2017 VS 2022
Figure 19. Global Top 10 TB Diagnostic Countries Ranking by Market Size (US$ Million) in 2021
Figure 20. Global TB Diagnostic Market Share by Players in 2021
Figure 21. Global Top TB Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in TB Diagnostic as of 2021)
Figure 22. The Top 10 and 5 Players Market Share by TB Diagnostic Revenue in 2021
Figure 23. North America TB Diagnostic Revenue Market Share by Company in 2021
Figure 24. North America TB Diagnostic Revenue Market Share by Type (2017-2028)
Figure 25. North America TB Diagnostic Revenue Market Share by Application (2017-2028)
Figure 26. North America TB Diagnostic Revenue Share by Country (2017-2028)
Figure 27. U.S. TB Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 28. Canada TB Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 29. Europe TB Diagnostic Revenue Market Share by Company in 2021
Figure 30. Europe TB Diagnostic Revenue Market Share by Type (2017-2028)
Figure 31. Europe TB Diagnostic Revenue Market Share by Application (2017-2028)
Figure 32. Europe TB Diagnostic Revenue Share by Country (2017-2028)
Figure 33. Germany TB Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 34. France TB Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 35. U.K. TB Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 36. Italy TB Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 37. Russia TB Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 38. Asia Pacific TB Diagnostic Revenue Market Share by Company in 2021
Figure 39. Asia Pacific TB Diagnostic Revenue Market Share by Type (2017-2028)
Figure 40. Asia Pacific TB Diagnostic Revenue Market Share by Application (2017-2028)
Figure 41. Asia Pacific TB Diagnostic Revenue Share by Region (2017-2028)
Figure 42. China TB Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 43. Japan TB Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 44. South Korea TB Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 45. India TB Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 46. Australia TB Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 47. Taiwan TB Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 48. Indonesia TB Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 49. Thailand TB Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 50. Malaysia TB Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 51. Philippines TB Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 52. Vietnam TB Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 53. Latin America TB Diagnostic Revenue Market Share by Company in 2021
Figure 54. Latin America TB Diagnostic Revenue Market Share by Type (2017-2028)
Figure 55. Latin America TB Diagnostic Revenue Market Share by Application (2017-2028)
Figure 56. Latin America TB Diagnostic Revenue Share by Country (2017-2028)
Figure 57. Mexico TB Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 58. Brazil TB Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 59. Argentina TB Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 60. Middle East and Africa TB Diagnostic Revenue Market Share by Company in 2021
Figure 61. Middle East and Africa TB Diagnostic Revenue Market Share by Type (2017-2028)
Figure 62. Middle East and Africa TB Diagnostic Revenue Market Share by Application (2017-2028)
Figure 63. Middle East and Africa TB Diagnostic Revenue Share by Country (2017-2028)
Figure 64. Turkey TB Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 65. Saudi Arabia TB Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 66. U.A.E TB Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 67. Abbott Laboratories Revenue Growth Rate in TB Diagnostic Business (2017-2022)
Figure 68. Abbott Revenue Growth Rate in TB Diagnostic Business (2017-2022)
Figure 69. Becton Dickinson and Company Revenue Growth Rate in TB Diagnostic Business (2017-2022)
Figure 70. bioMrieux Revenue Growth Rate in TB Diagnostic Business (2017-2022)
Figure 71. Cepheid Revenue Growth Rate in TB Diagnostic Business (2017-2022)
Figure 72. F. Hoffman La Roche Revenue Growth Rate in TB Diagnostic Business (2017-2022)
Figure 73. Hain Lifescience Revenue Growth Rate in TB Diagnostic Business (2017-2022)
Figure 74. Hologic Corporation Revenue Growth Rate in TB Diagnostic Business (2017-2022)
Figure 75. Thermo Fisher Scientific Revenue Growth Rate in TB Diagnostic Business (2017-2022)
Figure 76. Qiagen Revenue Growth Rate in TB Diagnostic Business (2017-2022)
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed